![]() Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | ||
Founding Date | Founding Date 1994 | Founding Date 2018 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | Locations South San Francisco, US HQ Bothell, US Seattle, US |
Employees | Employees 8174% decrease | Employees 188 |
Valuation ($) | Valuation ($) 96.2 m | Valuation ($) 243.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $114.2m (FY, 2025) | Revenue (est.) $36k (FY, 2025) |
Net income | Net income ($3.1m) (FY, 2025) | Net income ($274.4m) (FY, 2025) |

Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View company